NCT03374852 2025-04-29CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic CancerThomas Jefferson UniversityPhase 2 Withdrawn
NCT05854966 2024-09-19CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)Wake Forest University Health SciencesPhase 2 Withdrawn